Neostigmine-lidocaine admixture for tourniquet pain management in Bier's block

Fentanyl consumption for tourniquet pain management while using neostigmine-lidocaine admixture versus lidocaine in Bier's block for upper limb surgeries.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201801002886341

Enrollment

Registered

2017-12-17

Start date

2012-12-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury, Occupational Diseases, Poisoning Surgery upper limb surgeries Anaesthesia

Interventions

lidocaine

Neostigmine-lidocaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients submitted to elective forearm and hand surgeries. Age between 18-65 years. Males and females. ASA physical status I and II.

Exclusion criteria

Exclusion criteria: ¿ Patients suffering from any of the subsequent medical problems:bronchial asthma, Raynaud¿s disease, Sickle cell anaemia, cardiac conduction abnormalities. ¿ Allergy to either lidocaine and/or neostigmine. ¿ Emergency surgeries. ¿ Surgeries exceeding 1 hour duration. ¿ Patients subjected to general anesthesia during surgery.

Design outcomes

Primary

Measure	Time frame
intraoperative fentanyl consumption for each group.	—

Secondary

Measure	Time frame
Onset of tourniquet Pain.;Number of patients suffering from tourniquet pain.;VAS (Visual analogue scale);Time to first rescue analgesic.;Onset of sensory block.;Onset of motor block;Sensory recovery time.;Motor recovery time.	—

Countries

Egypt

Contacts

Public ContactHesham Abu el Dahab

Assistant professor of anesthesia, surgical intensive care and pain medicine, Cairo university

meshodoctor@gmail.com01016644419

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026